- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03954886
Defocus Induced Changes on Choroidal Thickness
Effects of Defocus on Choroidal Thickness
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to determine modifying factors inducing or protecting against the development or progression of myopia, or nearsightedness. Myopia has reached epidemic levels in urbanized countries, reaching up to 90% of the teenage and young adult population in urban Asia. Myopia represents a significant socioeconomic burden and poses a risk for associated ocular diseases such as retinal detachment, choroidal neovascularization, and glaucoma. The economic and public health burden of myopia are growing disproportionately to the population, spurring interest in the development of therapies to prevent occurrence or progression. Myopia generally occurs because the eye grows too long, with onset and progression occurring from about ages 6 to 20. Though much is known about factors that influence eye growth, the exact mechanisms by which they do so have not been elucidated.
The goals of this study are to assess the short-term (10-50 minutes) effects of different magnitudes of myopic and hyperopic optical defocus on the transient thickness of the choroid in children and adults, as well as to assess the recovery period. Choroidal thickness will be measured non-invasively following 10-50 minutes of monocular exposure to -5D to +5D of optical defocus induced by spectacle lenses. The hypothesis is that choroidal thickness will increase with increasing myopic defocus and decrease with increasing hyperopic defocus. The relationship between the magnitude of defocus and the magnitude and direction of choroidal thickness change will be assessed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77004
- University of Houston College of Optometry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 6 to 45 years of age (preliminary studies indicate that children under 6 cannot sit for imaging, and subjects over 45 do not respond to the optical defocus with expected choroidal thickness changes)
- Best corrected visual acuity of 20/25 or better in better-seeing eye
Exclusion Criteria:
- Age younger than 6 years or older than 45
- Best corrected visual acuity worse than 20/25 in better-seeing eye
- Ocular pathology or prior ocular injury
- Heavily-pigmented choroid that precludes accurate measurement of choroidal thickness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Induced myopic defocus
Subjects will view a television through a lens that induces blur to the retina for one hour.
Images of the eye will be captured every 10 minutes
|
A plus powered optical lens will be placed in front of one eye.
|
No Intervention: No defocus
Subjects will view a television through a lens that induces no blur to the retina for one hour.
Images of the eye will be captured every 10 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Choroidal thickness
Time Frame: 1 hour
|
Changes in choroidal thickness following induced myopic defocus
|
1 hour
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Induced Defocus to the Retina
-
Duke UniversityUniversity of North Carolina, Chapel Hill; Wallace H. Coulter FoundationCompleted
-
Cairo UniversityAin Shams University hospitalsUnknownthe Study Focus to Improve the Standard of Care Used for Aluminuim Phosphide Poisoning and to Save Patients With the Minimal Organ DamageEgypt
-
Tianjin University of Traditional Chinese MedicineNational Basic Research Program, ChinaCompletedto Evaluate the Effectiveness of Acupucnture in the Management of Chemotherapy-induced Nausea and VomitingChina
-
Nova Scotia Health AuthorityCompletedTime it Takes to Successfully Intubate the Patient With the GlideScope | Time to Intubate Between the Two ViewsCanada
-
Cairo UniversityUnknownEvaluation of the Accuracy of Transferring the Virtual Planning to the Surgery
-
UNC Lineberger Comprehensive Cancer CenterUNC Translational and Clinical Sciences (Tracs)CompletedA History of Radiation Therapy for a Tumor in the Vicinity of the Retina(s)United States
-
ActiViews Ltd.CompletedAccurate Navigation to the LesionCanada
-
Mansoura UniversityCompletedSurgery to the Distal One Third of the Upper LimbEgypt
-
IRCCS San RaffaeleCompletedSurgical and the Percutaneous Approach to the Upper Extremity AccessSpain, Sweden, Austria, Belgium, Germany, Switzerland, Italy, United States, France, United Kingdom
-
Kliniken Ludwigsburg-Bietigheim gGmbHKlinikum Ludwigshafen; Universitätsmedizin MannheimUnknownTo Evaluate Patency of the Viaduct Stent in Comparison to Metal StentsGermany
Clinical Trials on Plus powered optical lens
-
Ethicon Endo-SurgeryCompleted
-
CIBA VISIONBascom Palmer Eye InstituteCompletedOcular ComfortUnited States
-
University Hospital, Basel, SwitzerlandRecruitingLung Resection | Postoperative Air LeakSwitzerland
-
Aston UniversityNational Pollen and Aerobiology Unit, WorcesterCompletedGrass Pollen Ocular AllergyUnited Kingdom
-
CIBA VISIONUniversity of ManchesterCompleted
-
CIBA VISIONCompleted
-
Johnson & Johnson Surgical Vision, Inc.CompletedRefractive Error | CataractPhilippines, New Zealand, Spain
-
Ashford and St. Peter's Hospitals NHS TrustBausch & Lomb IncorporatedUnknown
-
Alcon ResearchCompletedRefractive ErrorUnited Kingdom